Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

[1]  M. Schenker,et al.  Ability of Thromboelastography to Detect Hypercoagulability: A Systematic Review and Meta-Analysis. , 2020 .

[2]  Matthieu Legrand,et al.  Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation , 2020, Intensive Care Medicine.

[3]  P. Navalesi,et al.  COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure , 2020, Thrombosis and Haemostasis.

[4]  L. Menicanti,et al.  The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome , 2020, Journal of Thrombosis and Haemostasis.

[5]  G. Grasselli,et al.  Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.

[6]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[7]  K. Hashimoto,et al.  Nervous system involvement after infection with COVID-19 and other coronaviruses , 2020, Brain, Behavior, and Immunity.

[8]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[9]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[10]  Yuanliang Xie,et al.  COVID-19 Complicated by Acute Pulmonary Embolism , 2020, Radiology. Cardiothoracic imaging.

[11]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[12]  Runsheng Wang,et al.  Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study , 2020, American journal of respiratory and critical care medicine.

[13]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[14]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[15]  Brown Wesley,et al.  The Ability of Thromboelastography to Detect Hypercoagulability: A Systematic Review & Meta-Analysis. , 2019, Journal of orthopaedic trauma.

[16]  H. Krumholz,et al.  PULMONARY EMBOLISM HOSPITALIZATIONS AND USE OF INFERIOR VENA CAVAL FILTERS IN OLDER ADULTS: NATIONAL STUDY OF MEDICARE BENEFICIARIES , 2019, Journal of the American College of Cardiology.

[17]  J. Dias,et al.  New-Generation Thromboelastography: Comprehensive Evaluation of Citrated and Heparinized Blood Sample Storage Effect on Clot-Forming Variables. , 2017, Archives of pathology & laboratory medicine.

[18]  M. Prasarn,et al.  Can Thrombelastography Predict Venous Thromboembolic Events in Patients With Severe Extremity Trauma? , 2016, Journal of orthopaedic trauma.

[19]  Matthew Wei,et al.  The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis , 2015, Hematology reports.

[20]  T. Baglin,et al.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[21]  G. Guyatt,et al.  Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.

[22]  Peter Bauer,et al.  SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission , 2005, Intensive Care Medicine.